Divis Labs Submits FY26 BRSR Report

Divis Laboratories Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. The report, which forms part of the Annual Report, details the company's operations, employee data, and market presence. Key disclosures include that the company's business activities, primarily the manufacture of Active Pharmaceutical Ingredients, Intermediates, and Nutraceuticals, account for 100% of its turnover. Exports constitute 89% of the total turnover, serving customers in 80 countries. The report also provides data on employee demographics, including a focus on differently-abled individuals and gender representation, as well as employee turnover rates.